Cargando…
Mutagenic and tumourigenic properties of the spores of Aspergillus clavatus.
Spore walls of a sputum-derived isolate of Aspergillus clavatus yielded mutagen(s) when their extracts were fractionally precipitated with ethanol following alkaline hydrolysis. After spores were given by nasal inoculation to 6-8-week-old CF-1 mice, light and electron microscopy of lung sections sho...
Autores principales: | , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1982
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2010971/ https://www.ncbi.nlm.nih.gov/pubmed/7059453 |
_version_ | 1782136433915461632 |
---|---|
author | Blyth, W. Hardy, J. C. |
author_facet | Blyth, W. Hardy, J. C. |
author_sort | Blyth, W. |
collection | PubMed |
description | Spore walls of a sputum-derived isolate of Aspergillus clavatus yielded mutagen(s) when their extracts were fractionally precipitated with ethanol following alkaline hydrolysis. After spores were given by nasal inoculation to 6-8-week-old CF-1 mice, light and electron microscopy of lung sections showed that they had been readily phagocytozed by the polymorphonuclear leucocytes and alveolar macrophages mobilized during early allergic alveolitis in immunized mice. The formation of phagosomes was followed in thioglycollate-stimulated peritoneal macrophages grown in vitro. Unimmunised mice showed a comparable lung reaction, attributed to pulmonary mycotoxicosis, and revealed a rising incidence of lung tumours, from 25% at 2 months from inoculation, to 27.3% at 6 and to 55.5% at 8. Mean numbers of tumours per lung rose from 1.0 to 2.2. Total tumours, including lymphomas, reached a final incidence of 77.7% at 8 months, when control animals were tumour-free. Tumour development correlated with the retention of apparently intact spores within giant cells probably derived from aggregates of alveolar macrophages. The implications of these findings in the light of the known history of human exposure to such spores is discussed. IMAGES: |
format | Text |
id | pubmed-2010971 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1982 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-20109712009-09-10 Mutagenic and tumourigenic properties of the spores of Aspergillus clavatus. Blyth, W. Hardy, J. C. Br J Cancer Research Article Spore walls of a sputum-derived isolate of Aspergillus clavatus yielded mutagen(s) when their extracts were fractionally precipitated with ethanol following alkaline hydrolysis. After spores were given by nasal inoculation to 6-8-week-old CF-1 mice, light and electron microscopy of lung sections showed that they had been readily phagocytozed by the polymorphonuclear leucocytes and alveolar macrophages mobilized during early allergic alveolitis in immunized mice. The formation of phagosomes was followed in thioglycollate-stimulated peritoneal macrophages grown in vitro. Unimmunised mice showed a comparable lung reaction, attributed to pulmonary mycotoxicosis, and revealed a rising incidence of lung tumours, from 25% at 2 months from inoculation, to 27.3% at 6 and to 55.5% at 8. Mean numbers of tumours per lung rose from 1.0 to 2.2. Total tumours, including lymphomas, reached a final incidence of 77.7% at 8 months, when control animals were tumour-free. Tumour development correlated with the retention of apparently intact spores within giant cells probably derived from aggregates of alveolar macrophages. The implications of these findings in the light of the known history of human exposure to such spores is discussed. IMAGES: Nature Publishing Group 1982-01 /pmc/articles/PMC2010971/ /pubmed/7059453 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Research Article Blyth, W. Hardy, J. C. Mutagenic and tumourigenic properties of the spores of Aspergillus clavatus. |
title | Mutagenic and tumourigenic properties of the spores of Aspergillus clavatus. |
title_full | Mutagenic and tumourigenic properties of the spores of Aspergillus clavatus. |
title_fullStr | Mutagenic and tumourigenic properties of the spores of Aspergillus clavatus. |
title_full_unstemmed | Mutagenic and tumourigenic properties of the spores of Aspergillus clavatus. |
title_short | Mutagenic and tumourigenic properties of the spores of Aspergillus clavatus. |
title_sort | mutagenic and tumourigenic properties of the spores of aspergillus clavatus. |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2010971/ https://www.ncbi.nlm.nih.gov/pubmed/7059453 |
work_keys_str_mv | AT blythw mutagenicandtumourigenicpropertiesofthesporesofaspergillusclavatus AT hardyjc mutagenicandtumourigenicpropertiesofthesporesofaspergillusclavatus |